Immunotech Laboratories, Inc. IMMB Company Overview 

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Immunotech Laboratories, Inc. IMMB Company Overview 

Stock Message Board http://investorshangout.com/search?q=IMMB&...mp;yt1=Go!

Immunotech Laboratories, Inc. IMMB Current Price and Quotes
Last Price 0.0375
Previous Close 0.032 Open 0.0375
Daily Range 0.0375 - 0.0375 52wk Range 0.45 - 0.0133
Volume 37,150 Dividend N/A
Average Vol (3m) 10,484 Yield N/A
Immunotech Laboratories, Inc. IMMB

Company Verified Profile
Company Information

120 W. Pomona Avenue
Monrovia, CA 91016

Website: http://www.immunotechlab.com
Phone: 818-409-9091
Email: immunotechlabs@gmail.com

Immunotech Laboratories, Inc. IMMB
Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Immunotech is committed to creating drugs for the better health of mankind.

Immunotech's flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin...



Immunotech Laboratories, Inc. IMMB
Financial Reportings and Disclosures

Reporting Status Alternative Reporting Standard
Deregistered a/o Jun 13, 2013
Audited Financials Audited
Latest Report Dec 31, 2009 10-K
CIK 0001137117
Fiscal Year End 12/31
OTC Marketplace OTC Pink Limited
Profile Data

SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o Feb 18, 2009
Incorporated In: NV, USA
Year of Inc. 2008
Employees 5 a/o Jul 08, 2013
Company Officers/Contacts

Harry Zhabilov CEO, President
Blaine Nabors VP, Business Development
Company Directors

Valentin Dimitrov
Bo Linton
Company Notes

Formerly=International Technology Systems, Inc. until 2-2009
Formerly=International Telecommunications, Inc. until 11-06
Formerly=EarthNetMedia, Inc. until 8-05
Note=12-31-04 company is in the development stage
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Law Offices of Joseph L. Pittera
2214 Torrance Boulevard, Suite 101
Torrance, CA, 90501
United States

Investor Relations Firm
The Nabors Group
CA, United States


Immunotech Laboratories, Inc. IMMB
IMMB Security Details

Share Structure

Market Value1 $25,781,112 a/o Sep 12, 2013
Shares Outstanding 687,496,325 a/o Jul 08, 2013
Float 9,000,000 a/o Jul 08, 2013
Authorized Shares 800,000,000 a/o Jul 08, 2013
Par Value  0.001
Shareholders

Shareholders of Record 356 a/o Jul 08, 2013
Security Notes

Capital Change=shs increased by 6 for 1 split. Effective date=1-21-03
Capital Change=shs decreased by 1 for 200 split Pay date=08/29/2005.
Capital Change=shs decreased by 1 for 100 split. Pay date=02/26/2009.
Short Selling Data

Short Interest 3,530 (100%)
Aug 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

Pacific Stock Transfer Co.

Immunotech Laboratories, Inc. IMMB Recent News

Jun 19, 2013 Immunotech Laboratories, Inc. Announces the Results From Gap Analysis Report


Immunotech Laboratories, Inc. IMMB Financials
IMMB


IMMB Immunotech Laboratories, Inc. Research DD Guide

IMMB Immunotech Laboratories, Inc. Stock Message Board http://investorshangout.com/search?q=IMMB&...mp;yt0=Go!
IMMB Immunotech Laboratories, Inc. Stock Quote http://www.otcmarkets.com/stock/IMMB/quote
IMMB Immunotech Laboratories, Inc. Stock Chart http://www.otcmarkets.com/stock/IMMB/chart
IMMB Immunotech Laboratories, Inc. Company Info http://www.otcmarkets.com/stock/IMMB/company-info
IMMB Immunotech Laboratories, Inc. Recent News http://www.otcmarkets.com/stock/IMMB/news
IMMB Immunotech Laboratories, Inc. Financials http://www.otcmarkets.com/stock/IMMB/financials
IMMB Immunotech Laboratories, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/IMMB/filings
IMMB Immunotech Laboratories, Inc. Short Sales http://www.otcmarkets.com/stock/IMMB/short-sales
IMMB Immunotech Laboratories, Inc. Insider Disclosure http://www.otcmarkets.com/stock/IMMB/insider-transactions
IMMB Immunotech Laboratories, Inc. Research Reports http://www.otcmarkets.com/stock/IMMB/research
IMMB Immunotech Laboratories, Inc. Summary http://finance.yahoo.com/q?s=IMMB
IMMB Immunotech Laboratories, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=IMMB+Historical+Prices
IMMB Immunotech Laboratories, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=IMMB
IMMB Immunotech Laboratories, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=IMMB+Basic+Chart
IMMB Immunotech Laboratories, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=IMMB+Basic+Tech.+Analysis
IMMB Immunotech Laboratories, Inc. Headlines http://finance.yahoo.com/q/h?s=IMMB+Headlines
IMMB Immunotech Laboratories, Inc. Press Releases http://finance.yahoo.com/q/p?s=IMMB+Press+Releases
IMMB Immunotech Laboratories, Inc. Company Profile http://finance.yahoo.com/q/pr?s=IMMB+Profile
IMMB Immunotech Laboratories, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=IMMB+Key+Statistics
IMMB Immunotech Laboratories, Inc. Industry http://finance.yahoo.com/q/in?s=IMMB+Industry
IMMB Immunotech Laboratories, Inc. Major Holders http://finance.yahoo.com/q/mh?s=IMMB+Major+Holders
IMMB Immunotech Laboratories, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=IMMB+Insider+Transactions
IMMB Immunotech Laboratories, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=IMMB+Insider+Roster
IMMB Immunotech Laboratories, Inc. Income Statement http://finance.yahoo.com/q/is?s=IMMB
IMMB Immunotech Laboratories, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=IMMB
IMMB Immunotech Laboratories, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=IMMB+Cash+Flow&annual
IMMB Immunotech Laboratories, Inc. Nasdaq http://www.nasdaq.com/symbol/IMMB
IMMB Immunotech Laboratories, Inc. Market Watch http://www.marketwatch.com/investing/stock/IMMB
IMMB Immunotech Laboratories, Inc. Bloomberg http://www.bloomberg.com/quote/IMMB:US
IMMB Immunotech Laboratories, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=IMMB
IMMB Immunotech Laboratories, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=IMMB
IMMB Immunotech Laboratories, Inc. Barchart http://www.barchart.com/quotes/stocks/IMMB
IMMB Immunotech Laboratories, Inc. OTC Short Report http://otcshortreport.com/index.php?index=IMMB
IMMB Immunotech Laboratories, Inc. Investopedia http://www.investopedia.com/markets/stocks/IMMB/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading